Mutual of America Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-212,781
| Closed | -$1.08M | – | 1455 |
|
|
2024
Q1 | $1.08M | Sell |
212,781
-8,771
| -4% | -$44.6K | 0.01% | 1033 |
|
|
2023
Q4 | $1.33M | Sell |
221,552
-3,771
| -2% | -$22.6K | 0.02% | 1015 |
|
|
2023
Q3 | $1.6M | Buy |
225,323
+5,589
| +3% | +$39.6K | 0.02% | 951 |
|
|
2023
Q2 | $1.55M | Buy |
219,734
+223
| +0.1% | +$1.57K | 0.02% | 980 |
|
|
2023
Q1 | $1.83M | Sell |
219,511
-156,317
| -42% | -$1.3M | 0.02% | 932 |
|
|
2022
Q4 | $4.31M | Buy |
375,828
+169,090
| +82% | +$1.94M | 0.05% | 531 |
|
|
2022
Q3 | $2.61M | Hold |
206,738
| – | – | 0.04% | 723 |
|
|
2022
Q2 | $2.19M | Sell |
206,738
-3,827
| -2% | -$40.5K | 0.03% | 838 |
|
|
2022
Q1 | $3.42M | Sell |
210,565
-1,293
| -0.6% | -$21K | 0.04% | 730 |
|
|
2021
Q4 | $2.93M | Buy |
211,858
+28,425
| +15% | +$394K | 0.03% | 834 |
|
|
2021
Q3 | $2.64M | Buy |
+183,433
| New | +$2.64M | 0.03% | 855 |
|